References
Anderson AM, Baranowska-Hustad M, Braathen R, Grodeland G, Bogen B. Simultaneous Targeting of
Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza. J Immunol. 2018 Mar
15;200(6):2057–2066.
Angamuthu M, Murthy SN. Therapeutic Applications of Electroporation. In: Dragicevic N, Maibach H, eds.
PercutaneousPenetrationEnhancersPhysicalMethodsinPenetrationEnhancement. Berlin, Heidelberg:
Springer;2017:122-137.
Bartoletti DC, Harrison GI. and Weaver JC. The number of molecules taken up by electroporated cells:
quantitative determination.FEBSLett. 1989:256:4-10.
Biragyn A, et al. Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T
cell-mediated protective and therapeutic antitumor immunity. J Immunol. 2007 Jul 15;179(2):1381-1388.
Bongard N, Lapuente D, Windmann S, Dittmer U, Tenbusch M, Bayer, W. Interference of Retroviral Envelope
with Vaccine-Induced CD8+ T Cell Responses is Relieved by Co-Administration of Cytokine-Encoding Vectors.
Retrovirology. 2017;14: 28.
Bråve A, et al. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed
T and B cell responses to carcinoembryonic antigen. Vaccine. 2009 Jun 8;27(28): 3692-3696.
Chang, DC, Chassy BM, Saunders JA and Sowers AE, eds. Guide to Electroporation and Electrofusion. San Diego:
Academic Press;1992.
Christopher W, et al, Long-term multilineage engraftment of autologous genome-edited hematopoietic stem
cells in nonhuman primates. Blood. 2016;127:2416-2426.
Daftarian MP, Vosoughi A, Lemmon V. Gene-Based Vaccination and Screening Methods to Develop Monoclonal
Antibodies. MethodsMolBiol. 2014;1121:337-346.
Davtyan H, et al. BTX AgilePulse(TM) System is an Effective Electroporation Device for Intramuscular and
Intradermal Delivery of DNA Vaccine. Curr Gene Ther. 2014;14(3):190-199.
Denies S, Cicchelero L, Polis I, Sanders NN. Immunogenicity and safety of xenogeneic vascular endothelial
growth factor receptor-2 DNA vaccination in mice and dogs. Oncotarget. 2016;7(10):10905-10916.
Denies S, et al. Evaluation of a Xenogeneic Vascular Endothelial Growth Factor-2 vaccine in Two Preclinical
Metastatic Tumor Models in Mice. Cancer Immunol Immunother. 2017 Dec;66(12):1545-1555.
Dimitrov DS, and Sowers AE. Membrane electroporation — fast molecular exchange by electroosmosis.
BiochimicaetBiophysicaActa. 1990 1022:381-392.
Djuzenova CS, Zimmermann U, Frank H, Sukhorukov VL, Richter E, Fuhr G. Effect of medium conductivity
and composition on the uptake of propidium iodide into electropermeabilized myeloma cells. Biochimicaet
BiophysicaActa. 1996;1284:143-152.
Disalvo EA and Simon SA, eds. Permeability and Stability of Lipid Bilayers. Boca Raton: CRC Press;1995.
Eyquem J, et al. Targeting a CAR to the TRAC Locus with CRISPR/Cas9 Enhances Tumour Rejection. Nature.
2017;543:113-117.
Gehl J. "Electroporation for Drug and Gene Delivery in the Clinic: Doctors Go Electric." ElectroporationProtocols.
Humana Press; 2008. 351-359.
Grodeland G, Fredriksen AB, Løset GÅ, Vikse E, Fugger L, Bogen B. Antigen Targeting to Human HLA Class II
Molecules Increases Efficacy of DNA Vaccination. J Immunol. 2016;197(9):3575-3585.
Hawksworth DJ, Ziemann R, Manoj S. Enhanced Immune Response Following DNA Immunization Through In
Vivo Electroporation. MonoclonAntibIImmunodiagnImmunother. 2016 Jul 27;35(5):239-244.
Johansson DX, Ljungberg K, Kakoulidou M, Liljestrom P. Intradermal Electroporation of Naked Replicon RNA
Elicits Strong Immune Responses. PLoSOne, 2012 Jan 4;7(1):e29732.
Juillerat A, et al. An Oxygen Sensitive Self-Decision Making Engineered CAR T-Cell. SciRep. 2017 Jan 20;7:39833.
Juillerat A, et al. Design of Chimeric Antigen Receptors with Integrated Controllable Transient Functions. SciRep.
2016 Jan 11;6:18950.
AgilePulse ID In Vivo Gene Delivery System
28
Publication 015-101444 Rev 2.0 • www.btxonline.com
Need help?
Do you have a question about the AgilePulse ID and is the answer not in the manual?